Department of Clinical Neurological Sciences, University Hospital, University of Western Ontario, London, Ontario, Canada.
Mayo Clin Proc. 2012 Aug;87(8):746-52. doi: 10.1016/j.mayocp.2012.02.020. Epub 2012 Jul 15.
To prospectively evaluate patients who met standard criteria for postural tachycardia syndrome (POTS), at baseline and 1-year follow-up, using standard clinical and laboratory methods to assess autonomic function.
Fifty-eight patients met the study criteria (orthostatic symptoms and a heart rate increment of ≥ 30 beats/min on head-up tilt) and completed 12 months of follow-up. All patients were enrolled and completed the study from January 16, 2006, through April 15, 2009. Patients underwent standardized autonomic testing, including head-up tilt, clinical assessment, and validated questionnaires designed to determine the severity of autonomic symptoms.
Patients were predominantly young females (n=49, 84%), with 20 patients (34%) reporting an antecedent viral infection before onset of symptoms. More than one-third (37%) no longer fulfilled tilt criteria for POTS on follow-up, although heart rate increment on head-up tilt did not differ significantly at 1 year (33.8 ± 15.1 beats/min) compared with baseline (37.8 ± 14.6 beats/min) for the entire cohort. Orthostatic symptoms improved in most patients. Autonomic dysfunction was mild as defined by a Composite Autonomic Severity Score of 3 or less in 55 patients (95%) at baseline and 48 patients (92%) at 1 year.
To our knowledge, this is the first prospective study of the clinical outcomes of patients with POTS. Orthostatic symptoms improved in our patients, with more than one-third of patients no longer fulfilling tilt criteria for POTS, although the overall group change in heart rate increment was modest. Our data are in keeping with a relatively favorable prognosis in most patients with POTS.
采用标准的临床和实验室方法评估自主神经功能,前瞻性评估符合体位性心动过速综合征(POTS)标准的患者在基线和 1 年随访时的情况。
58 名患者符合研究标准(直立症状和头高位倾斜时心率增加≥30 次/分)并完成了 12 个月的随访。所有患者均于 2006 年 1 月 16 日至 2009 年 4 月 15 日入组并完成了研究。患者接受了标准化的自主神经测试,包括头高位倾斜、临床评估和经过验证的问卷,旨在确定自主症状的严重程度。
患者主要为年轻女性(n=49,84%),有 20 名患者(34%)在症状发作前有前驱病毒感染。尽管整个队列在 1 年时的头高位倾斜心率增加与基线时(37.8±14.6 次/分)相比无显著差异(33.8±15.1 次/分),但随访时超过三分之一(37%)的患者不再符合 POTS 的倾斜标准。大多数患者的直立症状得到改善。根据复合自主严重程度评分(Composite Autonomic Severity Score),55 名患者(95%)在基线时和 48 名患者(92%)在 1 年时为 3 或以下,提示自主神经功能障碍较轻。
据我们所知,这是对 POTS 患者临床结局的第一项前瞻性研究。我们的患者直立症状得到改善,超过三分之一的患者不再符合 POTS 的倾斜标准,尽管总体心率增加的变化幅度较小。我们的数据与大多数 POTS 患者的预后相对较好相符。